Cell-specific biomarkers and targeted biopharmaceuticals for breast cancer treatment

Area of Science:

• Oncology
• Pharmacology

Background:

• Breast cancer remains a significant cause of mortality in women.
• Targeted therapy has emerged as a key precision treatment strategy.
• Biomarker identification is crucial for effective breast cancer treatment.

Purpose of the Study:

• To review cell-specific biomarkers for breast cancer classification and targeted therapy.
• To discuss innovative and generic targeted biopharmaceuticals for breast cancer.
• To provide an outlook on future developments and solutions in breast cancer biopharmaceuticals.

Main Methods:

• Literature review of targeted therapy in breast cancer.
• Analysis of cell-specific biomarkers and their role in treatment.
• Categorization of biopharmaceuticals including monoclonal antibodies, proteins, and small molecules.

Main Results:

• Cell-specific biomarkers are vital for breast cancer subtyping and therapeutic targeting.
• Various targeted biopharmaceuticals, including antibodies and small molecules, have shown efficacy.
• Significant advancements have been made in the targeted therapy of breast cancer.

Conclusions:

• Targeted therapy, guided by specific biomarkers, represents a major advancement in breast cancer treatment.
• Future developments in biopharmaceuticals hold promise for improved patient outcomes.
• Addressing current challenges is essential for the continued progress of breast cancer biopharmaceutical therapies.